Owens et al., 2020 - Google Patents
MOrPH-PhD: an integrated phage display platform for the discovery of functional genetically encoded peptide macrocyclesOwens et al., 2020
View PDF- Document ID
- 5964590255040319404
- Author
- Owens A
- Iannuzzelli J
- Gu Y
- Fasan R
- Publication year
- Publication venue
- ACS central science
External Links
Snippet
Macrocyclic peptides represent attractive scaffolds for targeting protein–protein interactions, making methods for the diversification and functional selection of these molecules highly valuable for molecular discovery purposes. Here, we report the development of a novel …
- 150000002678 macrocyclic compounds 0 title abstract description 95
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Owens et al. | MOrPH-PhD: an integrated phage display platform for the discovery of functional genetically encoded peptide macrocycles | |
Deyle et al. | Phage selection of cyclic peptides for application in research and drug development | |
Huang et al. | RNA display methods for the discovery of bioactive macrocycles | |
Guarracino et al. | Macrocyclic control in helix mimetics | |
Cromm et al. | Protease-resistant and cell-permeable double-stapled peptides targeting the Rab8a GTPase | |
JP6437468B2 (en) | Polypeptide modification | |
Rich et al. | Survey of the year 2001 commercial optical biosensor literature | |
Robinson | β-Hairpin peptidomimetics: design, structures and biological activities | |
Oppewal et al. | A strategy to select macrocyclic peptides featuring asymmetric molecular scaffolds as cyclization units by phage display | |
Li et al. | Cyclic Peptide Screening Methods for Preclinical Drug Discovery: Miniperspective | |
Smith et al. | Emerging strategies to access peptide macrocycles from genetically encoded polypeptides | |
Dietrich et al. | Peptides as drugs: from screening to application | |
CA2610976C (en) | Use of stefin a as a scaffold protein | |
Sawyer et al. | Hydrogen bond surrogate stabilization of β-hairpins | |
Ngambenjawong et al. | Engineering an affinity-enhanced peptide through optimization of cyclization chemistry | |
Anananuchatkul et al. | Construction of a stapled α-helix peptide library displayed on phage for the screening of galectin-3-binding peptide ligands | |
Bacon et al. | Isolation of chemically cyclized peptide binders using yeast surface display | |
Zhang et al. | Peptidomimetics targeting protein-protein interactions for therapeutic development | |
Merlino et al. | Functional selectivity revealed by N-methylation scanning of human urotensin II and related peptides | |
Liu et al. | Mutagenesis and evolution of sulfated antibodies using an expanded genetic code | |
Zhang et al. | High-throughput screening of stapled helical peptides in drug discovery | |
AU752168B2 (en) | Peptides causing formation of compact structures | |
Kaguchi et al. | Discovery of Biologically Optimized Polymyxin Derivatives Facilitated by Peptide Scanning and In Situ Screening Chemistry | |
Tombling et al. | Bioactive cyclization optimizes the affinity of a proprotein convertase subtilisin/kexin type 9 (PCSK9) peptide inhibitor | |
Shu et al. | Development of mirror-image screening systems for XIAP BIR3 domain inhibitors |